Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guardant Health, Inc. stock logo
GH
Guardant Health
$47.23
-4.6%
$43.48
$17.85
$50.89
$5.83B1.452.16 million shs3.56 million shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$12.92
+2.9%
$13.86
$6.62
$17.67
$1.11B1.32842,001 shs1.12 million shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$2.15
-0.9%
$2.28
$1.86
$4.17
$93.51M0.65195,960 shs108,135 shs
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$0.00
C$0.12
C$2.50
C$21.27MN/A68,686 shs239,293 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guardant Health, Inc. stock logo
GH
Guardant Health
+3.21%+13.08%+14.81%+3.95%+172.29%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
+1.78%+3.62%-11.11%-11.52%+39.47%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
+2.36%+3.83%-6.47%-30.89%-40.06%
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guardant Health, Inc. stock logo
GH
Guardant Health
3.9513 of 5 stars
2.54.00.04.32.72.50.6
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.0269 of 5 stars
3.23.00.00.02.91.70.0
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
2.4688 of 5 stars
3.52.00.00.03.31.70.6
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guardant Health, Inc. stock logo
GH
Guardant Health
3.05
Buy$49.003.75% Upside
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.33
Hold$16.7529.64% Upside
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.00
Buy$6.25190.70% Upside
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest QIPT, GH, MD, and TRL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/11/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$18.00 ➝ $16.00
4/10/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$60.00 ➝ $55.00
4/10/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$55.00
4/9/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/26/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$55.00 ➝ $55.00
3/6/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.00
2/26/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$34.00 ➝ $50.00
2/24/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$47.00 ➝ $52.00
2/24/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$56.00 ➝ $56.00
2/24/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$42.00 ➝ $60.00
2/21/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$49.00 ➝ $56.00
(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guardant Health, Inc. stock logo
GH
Guardant Health
$739.02M7.89N/AN/A$1.34 per share35.25
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$2.01B0.55$2.63 per share4.91$8.91 per share1.45
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$244.72M0.38$0.84 per share2.56$2.47 per share0.87
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$407.64M0.00N/A0.77C$0.38 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guardant Health, Inc. stock logo
GH
Guardant Health
-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%4/30/2025 (Estimated)
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-$60.41M-$1.20N/A9.641.74-4.92%15.47%5.64%5/6/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.17N/AN/AN/A-2.90%-6.70%-2.94%5/13/2025 (Estimated)
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/AC$6.340.04N/A0.86N/AN/AN/AN/A

Latest QIPT, GH, MD, and TRL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q2 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.02N/AN/AN/A$88.29 millionN/A
5/6/2025Q1 2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.25N/AN/AN/A$451.44 millionN/A
4/30/2025Q1 2025
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.57-$0.77-$0.20-$0.77$189.91 millionN/A
2/20/2025Q4 2024
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 million
2/20/2025Q4 2024
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.37$0.49+$0.12$0.36$486.22 million$502.36 million
2/10/2025Q1 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/A-$0.03N/A-$0.03N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$1.31704.17%N/A20.69%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
6.22
5.85
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.81
1.60
1.42
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.74
1.22
0.87
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/A
5.92
3.87

Institutional Ownership

CompanyInstitutional Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
97.71%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
42.85%
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
1,790123.42 million116.76 millionNot Optionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
7,85085.82 million84.16 millionOptionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
80043.09 million37.32 millionOptionable
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
70,00088.63 millionN/ANot Optionable

Recent News About These Companies

Trilogy International Partners Inc TRL.H
Trilogy International Ltd (TIL)
Trilogy International Partners GAAP EPS of -$0.03

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Guardant Health stock logo

Guardant Health NASDAQ:GH

$47.23 -2.30 (-4.64%)
As of 04:00 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$12.92 +0.36 (+2.87%)
As of 03:59 PM Eastern

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$2.15 -0.02 (-0.92%)
As of 04:00 PM Eastern

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Trilogy International Partners stock logo

Trilogy International Partners TSE:TRL

Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services in New Zealand, Bolivia, and internationally. It offers prepaid and postpaid payment plans, including local, international long distance, and roaming services to customers and international visitors roaming on its networks. The company also provides fixed broadband communications to residential and enterprise customers, as well as a range of mobile and fixed line services in New Zealand and Australia; and fixed public telephony and wireless broadband services in Bolivia. As of December 31, 2021, it had a distribution network of approximately 13 company owned stores, 170 dealers, and 8,300 other dealer points of presence in Bolivia; and a distribution network of approximately 20 company owned retail stores, 40 independent dealers, and 2,500 points of sale through national retail chains and grocery stores in New Zealand. The company's services cover an aggregate population of 16.8 million users. It also provides services through its online self-service store in New Zealand; and operates under the Viva brand name in Bolivia. Trilogy International Partners Inc. was founded in 1982 and is headquartered in Bellevue, Washington.